Chemoinformaics analysis of 5,7-DIHYDROXY-6-METHOXY-3-(4-METHOXYPHENYL)CHROMEN-4-ONE
| Molecular Weight | 314.293 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 18 |
| Exact Molecular Weight | 314.079 | nRing | 3 |
| Solubility: LogS | -3.624 | nHRing | 1 |
| Solubility: LogP | 2.935 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 42.5371 |
| nHD | 2 | BPOL | 20.1209 |
| QED | 0.772 |
| Synth | 2.326 |
| Natural Product Likeliness | 1.195 |
| NR-PPAR-gamma | 0.956 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.226 |
| Pgp-sub | 0.045 |
| HIA | 0.008 |
| CACO-2 | -4.833 |
| MDCK | 0.0000154 |
| BBB | 0.013 |
| PPB | 0.954875 |
| VDSS | 0.487 |
| FU | 0.0813686 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.905 |
| CYP2c19-inh | 0.806 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.859 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.681 |
| CYP2d6-sub | 0.874 |
| CYP3a4-inh | 0.511 |
| CYP3a4-sub | 0.2 |
| CL | 3.001 |
| T12 | 0.641 |
| hERG | 0.057 |
| Ames | 0.16 |
| ROA | 0.372 |
| SkinSen | 0.865 |
| Carcinogencity | 0.179 |
| EI | 0.862 |
| Respiratory | 0.249 |
| NR-Aromatase | 0.548 |
| Antiviral | Yes |
| Prediction | 0.778101 |